REACH: Why. Research. Matters.
REACH: Why. Research. Matters.REACH shares the stories of Penn State researchers: their studies, discoveries, and the ways their work shapes our world.
As a national leader in university research, with more than $900 million in annual funding, Penn State is at the forefront of tackling the challenges that matter most. Hosts Beth Bamford and Cole Cullen sit down with these experts to explore what they’re studying, why it matters, and how it impacts everyday lives and communities. From cross-disciplinary collaborations to partnerships with other universities and government agencies, REACH highlights the successes, challenges, and real-world impact of university research. Tune in to gain a deeper understanding of how research connects to you.
REACH shares the stories of Penn State researchers: their studies, discoveries, and the ways their work shapes our world.
As a national leader in university research, with more than $900 million in annual funding, Penn State is at the forefront of tackling the challenges that matter most. Hosts Beth Bamford and Cole Cullen sit down with these experts to explore what they’re studying, why it matters, and how it impacts everyday lives and communities. From cross-disciplinary collaborations to partnerships with other universities and government agencies, REACH highlights the successes, challenges, and real-world impact of university research. Tune in to gain a deeper understanding of how research connects to you.
Synthetic Blood
A team of Researchers, led by Dr. Dipanjan Pan of Penn State, have been developing synthetic blood for over a decade to address critical needs in emergency and battlefield medicine. Their nanoparticle-based product mimics red blood cells, delivering oxygen safely without the need for blood type matching or refrigeration. Designed as emergency bridging therapy, it helps trauma patients during transport. Biodegradable and long-lasting, this innovation addresses critical gaps in emergency care, supported by a multi-disciplinary team and startup.